SURPASS Impella 5.5 Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ahmad Zeeshan, MD
Advent Health Orlando
Principal Investigator - Anthony Lemaire, MD
Robert Wood Johnson University Hospital
Principal Investigator - David D'Alessandro, MD
MGH
Principal Investigator - Edward Soltesz, MD
The Cleveland Clinic
Principal Investigator - Fardad Esmailian, MD
Cedars-Sinai Medical Center
Principal Investigator - Gundars Katlaps, MD
Tampa General Hospital
Principal Investigator - Mark Anderson, MD
Hackensack Meridian Health
Principal Investigator - Masaki Funamoto, MD
Methodist San Antonio Hospital
Principal Investigator - Masashi Kawabori, MD
Tufts Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cedars Sinai Medical Center
Los Angeles, California, United States
- Advent Health Orlando
Orlando, Florida, United States
- Tampa General Hospital
Tampa, Florida, United States
- Emory University Hospital
Atlanta, Georgia, United States
- Northwestern University
Evanston, Illinois, United States
- Mgh
Boston, Massachusetts, United States
- Tufts Medical Center
Boston, Massachusetts, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- the Robert Wood Johnson University Hospital
New Brunswick, New Jersey, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Integris Health Baptist Medical Center
Oklahoma City, Oklahoma, United States
- University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Memorial Hermann Texas Medical Center
Houston, Texas, United States
- Methodist San Antonio Hospital
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Sept 2020
- Primary completion
- 14 May 2025
- Completion
- 14 May 2025
- Last update posted
- 20 May 2025
- Registered enrollment
- 1,017
- Registry id
- NCT05100836
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.